189 related articles for article (PubMed ID: 11328420)
1. Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study.
Sakamoto N; Naito S; Kumazawa J; Ariyoshi A; Osada Y; Omoto T; Fujisawa Y; Morita I; Yamashita H;
Int J Urol; 2001 May; 8(5):212-6. PubMed ID: 11328420
[TBL] [Abstract][Full Text] [Related]
2. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
O'Brien T; Ray E; Singh R; Coker B; Beard R;
Eur Urol; 2011 Oct; 60(4):703-10. PubMed ID: 21684068
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
Tari K; Satake I; Kojima S; Negishi T; Yoshida K; Nakame Y; Kanaoya F; Horiuchi S; Saito T; Owada F
Hinyokika Kiyo; 1987 Jun; 33(6):852-6. PubMed ID: 3118664
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
Freifeld Y; Ghandour R; Singla N; Woldu S; Bagrodia A; Lotan Y; Rapoport LM; Gazimiev M; Delafuente K; Kulangara R; Robyak H; Petros FG; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Sep; 38(9):737.e11-737.e16. PubMed ID: 32641241
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinoma].
Kudoh T; Motomura F; Saitoh F; Kogawa T; Suzuki T
Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1857-60. PubMed ID: 2292818
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
9. Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
Naito S; Iguchi A; Sagiyama K; Ariyoshi A; Osada Y; Omoto T; Kuriya N; Kumazawa J
Int J Urol; 1997 Jul; 4(4):352-7. PubMed ID: 9256323
[TBL] [Abstract][Full Text] [Related]
10. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
El-Ghobashy S; El-Leithy TR; Roshdy MM; El-Ganzoury HM
J Egypt Natl Canc Inst; 2007 Jun; 19(2):121-6. PubMed ID: 19034342
[TBL] [Abstract][Full Text] [Related]
13. Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.
Miyata Y; Tsurusaki T; Hayashida Y; Imasato Y; Takehara K; Aoki D; Nishikido M; Watanabe J; Mitsunari K; Matsuo T; Ohba K; Taniguchi K; Sakai H;
BJU Int; 2022 Apr; 129(4):534-541. PubMed ID: 34383381
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence].
Yasumoto R; Asakawa M; Yoshihara H; Sakamoto W; Iseki T; Nakatani T; Wada S; Kishimoto T; Maekawa M; Nishio S
Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.
Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A
BMC Urol; 2015 May; 15():45. PubMed ID: 26018765
[TBL] [Abstract][Full Text] [Related]
16. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin].
Kumamoto Y; Tsukamoto T; Tamiya T; Takatsuka K; Furuya S; Yokoyama E; Honma A; Aoyama T; Tanda H; Kato S
Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659
[TBL] [Abstract][Full Text] [Related]
17. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
[TBL] [Abstract][Full Text] [Related]
18. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
[TBL] [Abstract][Full Text] [Related]
19. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.
Tolley DA; Parmar MK; Grigor KM; Lallemand G; Benyon LL; Fellows J; Freedman LS; Grigor KM; Hall RR; Hargreave TB; Munson K; Newling DW; Richards B; Robinson MR; Rose MB; Smith PH; Williams JL; Whelan P
J Urol; 1996 Apr; 155(4):1233-8. PubMed ID: 8632538
[TBL] [Abstract][Full Text] [Related]
20. [Mitomycin-C 30 mg for 12 months versus Mitomycin-C 40 mg for 6 months in the prevention of superficial bladder carcinoma G1-G2].
Vecchioli Scaldazza C
Minerva Urol Nefrol; 1996 Dec; 48(4):203-6. PubMed ID: 9005589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
